Ophthalmic CRO Ora kept in ocular clinical trial pact with Axim by Angus Liu Wednesday, March 29, 2017 Axim Biotechnologies, which explores medical uses of cannabis, has decided to continue contracting Ora to manage its drug R&D activities and clinical trials on glaucoma and dry eye.
